Compare ADNT & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADNT | ATEC |
|---|---|---|
| Founded | 2016 | 1990 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2016 | 2006 |
| Metric | ADNT | ATEC |
|---|---|---|
| Price | $21.30 | $10.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $25.41 | $22.00 |
| AVG Volume (30 Days) | 621.2K | ★ 2.3M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $17,439,000,000.00 | $101,739,000.00 |
| Revenue This Year | $2.71 | $18.97 |
| Revenue Next Year | $2.36 | $16.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 7.56 | N/A |
| 52 Week Low | $11.89 | $9.11 |
| 52 Week High | $27.32 | $23.29 |
| Indicator | ADNT | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 50.85 | 45.52 |
| Support Level | $18.69 | $10.36 |
| Resistance Level | $21.76 | $16.22 |
| Average True Range (ATR) | 0.82 | 0.68 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 41.05 | 48.88 |
Adient began trading Oct. 31, 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market including unconsolidated joint venture business. Its share in China is around 20%, down from about 45%, following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025 and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (Sept. 30 year-end) consolidated revenue, which excludes joint venture sales, was $14.5 billion.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.